Sax Wealth Advisors LLC Has $748,000 Holdings in Danaher Co. (NYSE:DHR)

Sax Wealth Advisors LLC increased its stake in Danaher Co. (NYSE:DHR - Free Report) by 83.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,260 shares of the conglomerate's stock after purchasing an additional 1,485 shares during the period. Sax Wealth Advisors LLC's holdings in Danaher were worth $748,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. FMR LLC boosted its position in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. Legal & General Group Plc boosted its holdings in Danaher by 2.4% during the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock worth $1,490,112,000 after buying an additional 139,989 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Danaher by 3.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock worth $1,417,342,000 after buying an additional 148,251 shares during the period. Fisher Asset Management LLC raised its position in shares of Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock valued at $1,265,725,000 after acquiring an additional 116,299 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after acquiring an additional 535,254 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 1.4 %

Shares of NYSE:DHR traded down $3.49 during trading on Friday, hitting $238.41. 3,044,734 shares of the company were exchanged, compared to its average volume of 2,640,177. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The stock has a market cap of $172.20 billion, a price-to-earnings ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average price of $234.85 and a two-hundred day moving average price of $253.42.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 earnings per share. As a group, research analysts anticipate that Danaher Co. will post 7.49 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher's dividend payout ratio is 20.61%.

Analyst Ratings Changes

Several equities research analysts have commented on DHR shares. TD Cowen upped their target price on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They issued a "buy" rating and a $275.00 target price for the company. Bank of America upgraded Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective on the stock in a report on Friday, December 13th. Finally, Stephens reissued an "overweight" rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.